AI Article Synopsis
- Advance heart failure (AHF) is increasingly common, leading to serious health issues and high death rates, but left ventricular assist devices (LVADs) can help improve survival and quality of life.
- Despite their benefits, LVADs come with complications and challenges in wider application, prompting the need for additional therapies and technological advancements to reduce risks.
- The text reviews the history, clinical results, current challenges, and future possibilities for LVAD use in treating AHF.
Article Abstract
Advance heart failure (AHF) is a growing epidemic with high morbidity and mortality. Left ventricular assist device (LVAD) has come to offer an opportunity to improve survival and quality of life. This form of therapy however, is not free of complications and poses a challenge to apply to a broader population. Adjunct therapies in combination with LVAD therapy and advances in device technology are in the near future, which may lessen the number of adverse events. This review summarizes the history, clinical outcomes and current challenges facing LVAD therapy. Finally, future directions of LVADs in the treatment of AHF are discussed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.pcad.2016.01.006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!